Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NOMAC-E2 vs DRSP-EE for Contraception
NCT00511199Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- May 2006
- Primary completion
- Apr 2008
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, open-label trial of nomegestrol acetate + estradiol in contraception (2 arms), sponsored by Organon & Co. Primary endpoint: Number of In-treatment Pregnancies Per 100 Woman Years of Exposure (Pearl Index) at 1 year. Started May 2006; status: completed.
02
Drugs
nomegestrol acetate + estradiol
03
Conditions
contraception
Beyond the preview
Go deeper on NCT00511199.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00511199.